Disc Medicine (IRON) Assets Average (2020 - 2026)
Disc Medicine (IRON) reported Assets Average of $778.5 million for Q1 2026, up 29.11% year-over-year from $603.0 million in Q1 2025, and up 8.33% quarter-over-quarter from $718.7 million in Q4 2025.
Disc Medicine (IRON) Assets Average (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Assets Average data on file, last reported at $778.5 million in Q1 2026.
- Assets Average for Q1 2026 came in at $778.5 million, up 29.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $778.5 million (up 29.11% YoY), and the FY2025 annual result was $651.8 million, up 50.75% from the prior year.
- Assets Average rose to $778.5 million in Q1 2026 per IRON's latest filing, from $718.7 million in the prior quarter.
- Over five years, Assets Average peaked at $778.5 million in Q1 2026 and troughed at $108.3 million in Q1 2022.
- A 5-year average of $412.1 million and a median of $380.3 million in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2023: Assets Average plunged 34.32% in 2022, then surged 246.76% in 2023.
- A 5-year view of Assets Average shows it stood at $153.1 million in 2022, then jumped by 143.11% to $372.2 million in 2023, then jumped by 33.23% to $496.0 million in 2024, then surged by 44.9% to $718.7 million in 2025, then gained by 8.33% to $778.5 million in 2026.
- Business Quant data shows IRON's Assets Average at $778.5 million in Q1 2026, $718.7 million in Q4 2025, and $647.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | 778.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 778.55 Mn |
| Dec 31, 2025 | 718.67 Mn |
| Sep 30, 2025 | 647.76 Mn |
| Jun 30, 2025 | 687.16 Mn |
| Mar 31, 2025 | 603.02 Mn |
| Dec 31, 2024 | 495.96 Mn |
| Sep 30, 2024 | 502.68 Mn |
| Jun 30, 2024 | 432.20 Mn |
| Mar 31, 2024 | 361.09 Mn |
| Dec 31, 2023 | 372.25 Mn |
| Sep 30, 2023 | 380.34 Mn |
| Jun 30, 2023 | 313.98 Mn |
| Mar 31, 2023 | 221.99 Mn |
| Dec 31, 2022 | 153.12 Mn |
| Sep 30, 2022 | 109.68 Mn |
| Jun 30, 2022 | 118.81 Mn |
| Mar 31, 2022 | 108.35 Mn |
| Dec 31, 2021 | 123.97 Mn |
| Sep 30, 2021 | 163.98 Mn |
| Jun 30, 2021 | 180.90 Mn |